Gastrointestinal Beriberi Presenting With Chronic Diarrhea: A Case Report
Ryoma Ouchida1, Masataka Kudo1
1Department of General Internal Medicine, Iizuka Hospital, Iizuka, JPN.
Abstract:
Gastrointestinal beriberi is an underrecognized yet important manifestation of thiamine deficiency that may occur even in individuals without a history of chronic alcohol use. It often presents with nonspecific upper gastrointestinal symptoms, leading to diagnostic delay. The case of a woman in her 60s with a history of distal gastrectomy who developed persistent anorexia and intractable diarrhea over four months, resulting in multiple hospitalizations, is presented. Despite comprehensive evaluations, including blood tests, CT scans, stool analyses, endoscopy, and biopsies, no definitive cause was identified. Furthermore, she was not taking any medications that might have contributed to the diarrhea. She had no recent alcohol misuse, neurological deficits, or lactic acidosis, which are classical features typically associated with thiamine deficiency. Given her surgical history and ongoing symptoms, thiamine deficiency was suspected. A serum thiamine level measured on hospital day one was low at 14 ng/ml (reference range 26-58), which was consistent with thiamine deficiency. Oral thiamine led to the rapid resolution of symptoms within one week, and we therefore diagnosed thiamine deficiency. This case highlights gastrointestinal beriberi as an early, isolated manifestation. Diarrhea was the predominant symptom, a less-reported feature. Early recognition and treatment may prevent serious complications such as Wernicke's encephalopathy, even without classic risk factors.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...


